+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells



Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells



Breast Cancer Research and Treatment 112(2): 217-227



More than 20 different PIK3CA gene mutations were identified in breast cancer with different frequencies. Whether these breast cancer associated mutations have similar biological effects is largely unknown. In this study, we established a novel cell model using the lentivirus system to express 10 different PIK3CA genes (wild type and mutant) based on the human mammary epithelial cell MCF10A. We found that nine different PIK3CA mutants harbor different abilities to promote cell proliferation and EGF independent growth. In addition, most PIK3CA mutants (except for the wild type PIK3CA, the Q60K and the K111N mutants) had the ability to change the morphogenesis of the MCF10A cell in 3D Matrigel assay. Moreover, different PIK3CA mutants have different abilities to promote colony formation and cell invasion. We further observed that most of the PIK3CA mutants could activate p-AKT and p-p70-S6K in the absence of EGF stimulation. Finally, LY294002, a PI3K inhibitor, can effectively inhibit cell growth in cell lines with different PIK3CAs. Taken together, our results support the notion that different PIK3CA mutations differentially contribute to breast cancer transformation, and exploration of the therapeutic application of these mutations will benefit breast cancer patients with the PIK3CA mutations.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269842

Download citation: RISBibTeXText

PMID: 18074223

DOI: 10.1007/s10549-007-9847-6


Related references

Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Research 65(23): 10992-11000, 2005

Cooperative oncogenic effect and cell signaling crosstalk of co‑occurring HER2 and mutant PIK3CA in mammary epithelial cells. International Journal of Oncology 51(4): 1320-1330, 2017

Growth effects of oncogenic Raf-1 on finite lifespan and immortal cultured human mammary epithelial cells. Molecular Biology of the Cell 11(Supplement): 460a-461a, 2000

p53 Attenuates the oncogenic Ras-induced epithelial-mesenchymal transition in human mammary epithelial cells. Biochemical and Biophysical Research Communications 434(3): 606-613, 2013

Oncogenic mutations of PIK3CA in human cancers. Current Topics in Microbiology and Immunology 347: 21-41, 2011

Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 3(10): 1221-1224, 2004

PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells. Cancer Biology and Therapy 11(3): 358-367, 2011

AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell 16(1): 21-32, 2009

Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha. Cell Cycle 7(9): 1151-1156, 2008

Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6(7): 1189-1194, 1991

Transformation of human mammary epithelial cells with oncogenic retroviruses. Journal of Cellular Biochemistry Supplement (10 PART A): 24, 1986

Transformation of human mammary epithelial cells by oncogenic retroviruses. Cancer Research 48(16): 4689-4694, 1988

Mammary Epithelial-Myoepithelial Carcinoma: Report of a Case With HRAS and PIK3CA Mutations by Next-Generation Sequencing. International Journal of Surgical Pathology 2018: 1066896918821182-1066896918821182, 2018

Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Cancer Research 65(1): 317-324, 2005

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes and Development 15(1): 65, 2001